Defeat Duchenne Canada is committed to bringing the latest in Duchenne muscular dystrophy research and drug development to you – our Canadian Duchenne community. Complete the Registration Form below to receive the link.

Webinar Series: Updates on SGT-003, a next generation gene therapy from Solid Biosciences

Please join Defeat Duchenne Canada and Solid Biosciences team for a community webinar on May 27 at 1:00 PM ET. Annie Ganot, Co-Founder and SVP of Patient Advocacy, and Patrick Gonzalez, PhD, VP and Head of Clinical Science, will provide an update on SGT-003, our investigational next-generation gene therapy for Duchenne. They will also provide an overview of Solid’s two ongoing Duchenne clinical trials: the Phase 1/2 INSPIRE DUCHENNE trial and the Phase 3 IMPACT DUCHENNE trial.

Solid Biosciences Webinar Participants:

• Annie Ganot, Co-founder, SVP Patient Advocacy
• Patrick Gonzalez, PhD., VP, Head of Clinical Science

Complete the Registration Form below to receive the link.